Three linkage studies of bipolar disorder have implicated chromosome 12q24.3 with lod scores of over 3.0 and several other linkage studies have found lods between 2 and 3. Fine mapping within the original chromosomal linkage regions has identified several loci that show association with bipolar disorder. One of these is the P2RX7 gene encoding a central nervous system-expressed purinergic receptor. A non-synonymous single nucleotide polymorphism, rs2230912 (P2RX7-E13A, G allele) and a microsatellite marker NBG6 were both previously found to be associated with bipolar disorder (P = 0.00071 and 0.008, respectively). rs2230912 has also been found to show association with unipolar depression. The effect of the polymorphism is non-conservative and results in a glutamine to arginine change (Gln460Arg), which is likely to affect P2RX7 dimerization and protein-protein interactions. We have confirmed the allelic associations between bipolar disorder and the markers rs2230912 (P2RX7-E13A, G allele, P = 0.043) and NBG6 (P = 0.010) in a London-based sample of 604 bipolar cases and 560 controls. When we combined these data with the published case-control studies of P2RX7 and mood disorder (3586 individuals) the association between rs2230912 (Gln460Arg) and affective disorders became more robust (P = 0.002). The increase in Gln460Arg was confined to heterozygotes rather than homozygotes suggesting a dominant effect (odds ratio 1.302, CI = 1.129-1.503). Although further research is needed to prove that the Gln460Arg change has an aetiological role, it is so far the most convincing mutation to have been found with a role for increasing susceptibility to bipolar and genetically related unipolar disorders.
Introduction
Bipolar affective disorder (BPD (MIM 125480)) has a lifetime risk of 0.3-1.5%. Classical genetics studies have demonstrated that inherited factors contribute strongly to the aetiology of bipolar disorder and genetically related unipolar affective disorders. [1] [2] [3] The first reported linkage to bipolar disorder on 12q23-24.1 was suggested in a study by Dawson et al. 4 with a maximum lod score of 2.11. Stronger evidence of linkage to BPD on chromosome 12q24 was published with a lod of 3.37. 5 Other linkage studies found a lod of 1.24 in the United States, 6 followed by lods of 3.92 and then 5.50 from a French Canadian isolate 7, 8 and a lod of 2.80 in a sample from the United Kingdom and Iceland. 9 Studies of the genetically isolated population of the Faroe Islands also showed evidence for increased haplotype sharing and association on 12q24 in bipolar subjects. 10 Further linkage studies and observation of recombinants in bipolar disorder families identified a critical region of 6.5 Mb on 12q23-24.
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More recently linkage analyses of families affected by unipolar affective disorder showed linkage with a lod of 4.60 at the more centromeric region of 12q22-23.2. 12 A further linkage study generated a lod of 1.6 between markers at 12q23.3-24.3 and unipolar affective disorder. 13 A combined linkage analysis of these two unipolar samples confirmed linkage (P = 0.00004) at the Abkevich 12q22-23.2 locus. 13 Taken together, these results provide good support for the existence of a region influencing susceptibility to affective disorder at 12q23-14.1 and suggestive evidence for second region at 12q22-23.2. These linkage findings have been developed further by using tests of allelic association in case-control, trio and family samples in order to identify exactly which gene could be responsible for genetic susceptibility to bipolar and related unipolar disorders.
Shink et al. 14 first found allelic association between two microsatellite markers with bipolar disorder on 12q24 (NBG6, P = 0.008; NBG12, P < 0.0001). In the region surrounding NBG12 thirty-two genes were screened for potential aetiological polymorphisms. Two uncommon polymorphisms were found in the KIAA1595 and FLJ22471 genes that were then also found to be associated with bipolar disorder. The multi-allelic microsatellite marker NBG6 maps to intron 9 of the P2RX7 gene. P2RX7 and the neighbouring genes P2RX4 and CAMKK2 were also screened for potential aetiological polymorphisms. Association with bipolar disorder was detected with polymorphisms in P2RX7, P2RX4 and CAMKK2 (P2RX4-UTR3A, rs11065501, P = 0.018; P2RX7-E13A, rs2230912, Gln460Arg, P = 0.0007; CAMKK2-E01B, rs3817190, P = 0.015).
15 rs2230912 has shown some evidence for association with major depression (genotypic association P = 0.0019; allelic association P = 0.061). 16 Another region of 150 kb which is distant from P2RX7, in the12q23-24 region, encompassing the genes CUX2 and FLJ32356 has been studied in a UK case-control sample. 17 Allelic association was identified with one microsatellite marker (P = 0.0016), two single nucleotide polymorphisms (SNPs) (rs3847953, P = 0.002; rs933399, P = 0.004) and an insertion/deletion with putative functional relevance (P = 0.005). 17 Our own group has also published evidence for allelic and haplotypic association in two separate case-control samples with a total of 12 significantly associated microsatellite and SNP markers on 12q24. Eleven of these were in a region of 181kb that contains a number of incompletely characterized expressed sequences one of which is called Slynar or AY070435. AY070435 is known to be expressed in primate brain tissue. 18 Two SNPs rs203368 (P = 0.020) and rs435136 (P = 0.012) in the Citron gene on 12q24 were also found to be associated with bipolar disorder. 19 The Citron gene is a potential functional candidate for bipolar disorder on the basis that it interacts with the gene disrupted in schizophrenia (DISC1). One microsatellite marker and several SNP haplotypes, but not any individual SNPs, Significant results are in bold. Abbreviation: BPD, bipolar affective disorder.
A P2RX7 amino-acid change in mood disorders A McQuillin et al in or near the regulatory factor X4, transcription factor gene on 12q23.11 have also shown association with bipolar disorder. 20 Finally an SNP at the DAO locus on 12q has also been reported to show association with bipolar disorder (P = 0.01). 21 The DAO locus has also been implicated in schizophrenia. 22 DAO interacts with DAOA (G72) on chromosome 13 and this locus has also been shown to be associated with schizophrenia, bipolar disorder and panic disorder. [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] We set out to replicate the association findings with P2RX7 in our UK bipolar disorder case-control sample and to carry out a combined analysis of previous studies. Our results largely confirm the previous findings and strengthen the evidence for a role for P2RX7 in susceptibility to mood disorders.
Materials and methods
The UK/UCL sample consisted of 613 bipolar individuals with 560 psychiatrically screened normal controls. To address the issue of population stratification, participation was restricted to individuals of UK and Irish background. Individuals with not more than one grandparent of other Western European ancestry were also included. UK National Health Service Multicentre Research Ethics Committee approval was obtained and all subjects signed a consent form after reading an information sheet. All subjects were interviewed using the lifetime version of the Schizophrenia and Affective Disorders Schedule and assigned a research diagnostic criteria (RDC) diagnosis. Altogether 97% of the bipolar sample consisted of bipolar 1 cases and 3% were bipolar 2 subtype. Therefore 97% of our sample had psychotic features with manic syndrome and were diagnosed as bipolar 1 according to RDC and diagnostic and statistical manual III revised (DSMIIIR) criteria.
Genomic DNA was extracted from whole blood using standard methods. Two microsatellites and seven SNPs at the P2RX7 locus were genotyped. In addition all DNA samples from the bipolar individuals were PCR screened for an exon 13 deletion polymorphism 15 using the following primers: forward-TTCCTGGACAACCAGAGGAG and reverse-GAACAGCTCTGAGGTGGTGA. PCR products were separated by agarose gel electrophoresis. Microsatellite marker NBG6 was genotyped using primer sequences from Shink et al.
14 The second microsatellite was identified from the genomic sequence of P2RX7 from the UCSC Genome Browser. A tetranucleotide repeat mapping to intron 1 was selected (P2RX73). The primers used for P2RX73 were as follows: forward-TGCAGCCACGTTTGTAACAT and reverse-CTACTTGGGAGGCTGAGGTG. PCR amplification of microsatellites was achieved using standard protocols. One of the PCR primers contained an additional 19bp M13 tail and the PCR reactions included a fluorescently labelled M13 primer. Labelled PCR products were separated and detected on Li-Cor DNA4200 sequencers (LI-COR, Lincoln, NE, USA).
Genotype scoring was performed using SAGA-GT (Li-Cor). Two researchers scored the genotypes independently and any discrepant genotypes were repeated. Assays were designed for seven SNPs from the original Barden study rs208293 (P2RX7-I04B), rs208294 (P2RX7-E05A), rs504677 (P2RX7-I07E), rs1718119 (P2RX7-E11B), rs2230912 (P2RX7-E13A), rs11065501 (P2XR4-UTR3A) and rs3817190 (CAMKK2-E01B). 15 Two of these SNPs (rs7958311 (P2RX7-E08A) and rs2230911 (P2XR7E11C)) failed to give reliable genotypes and were abandoned. Genotyping was carried out by Kbiosciences (Kbiosciences, Hoddesdon, UK) using Kaspar (Kbiosciences). A total of 17% of samples was duplicated on the DNA plates to test for consistent allele scoring. Genotyping was initially carried out on the 604 bipolar samples and 450 controls available to us. Subsequently 110 additional control samples were recruited and these samples were typed for rs208294 (P2RX7-E05A) and rs2230912 (P2RX7-E13A). SNP and microsatellite data were tested for allelic association using w 2 -and empirical CLUMP 32 methods of analysis. The quality of the data was also assessed using SCANGROUP that can identify significant differences in haplotype frequencies between 96-well DNA plates and thus highlight potential genotyping errors, which tend to occur within single microtitre plates. 33 GENECOUNTING Figure 1 Marker to marker linkage disequilibrium between single nucleotide polymorphism (SNPs) at the P2RX7 locus. D 0 statistics are shown in deeper shading as they approach 1. Haplotype blocks are defined by a solid spine of linkage disequilibrium (LD) D 0 > 0.8. A P2RX7 amino-acid change in mood disorders A McQuillin et al was used for tests of marker to marker linkage disequilibrium (LD) and tests of haplotypic association with permutation. 33, 34 Analysis of haplotype block structure and individual haplotype association tests were performed using HAPLOVIEW. 35 
Results
The 21 bp deletion in exon thirteen of P2RX7 15 was not observed in any of the bipolar disorder individuals. The data for six of the seven SNPs were in Hardy-Weinberg equilibrium (HWE) for the control samples. SNP rs11065501 showed a modest departure from HWE (P = 0.027). Statistically significant evidence for allelic association with bipolar disorder was obtained from the microsatellite NBG6 (P = 0.01) and the SNP rs2230912 (P = 0.043; Tables 1 and 2 ). High levels of LD were observed between markers NBG6 and rs2230912 (D 0 = 0.976). Values for SNP inter-marker LD were generated for haplotype blocks exhibiting a spine of LD with a D 0 of > 0.8 using HAPLOVIEW (Figure 1 ). This analysis defined two such blocks. Block one consisted of two SNPs: rs208293 (P2RX7-I04B) and rs208294 (P2RX7-E05A). Block two consisted of three SNPs: rs504677 (P2RX7-I07E), rs1718119 (P2RX7-E11B) and rs2230912 (P2RX7-E13A). This block covers the region that includes the microsatellite marker NBG6 (see Table  1 for marker positions). Haplotype analysis of the SNP data as shown in Table 3 for block two using GENECOUNTING revealed significant association with BPD using data from SNPs rs504677 (P2RX7-I07E) and rs2230912 (P2RX7-E13A) (global empirical P = 0.0079; Table 3 ). Further analysis of the individual haplotypes from this analysis using HAPLOVIEW revealed two significantly associated haplotypes. The frequency of haplotype TG was estimated to be 14% in control chromosomes and 18% in subjects with bipolar disorder (empirical permutation P = 0.03), haplotype TA was estimated to be found in 29% in controls and 24% in bipolar subjects (empirical P = 0.027). Additional analysis of haplotype association with GENECOUNTING using combinations of the SNPs produced further evidence for association (global empirical P = 0.029-0.0037; Table 3 ). These results have not been corrected for multiple testing and therefore any interpretation of these significance values should take this into account. No correction for multiple testing has been applied because the appropriate method for correcting these analyses is not clear.
Data for association between rs2230912 (P2RX7-E13A) and bipolar disorder was published in the first P2RX7 bipolar study 15 and also in a follow-up study on major depression. 16 The minor allele (G) in all three studies was found at an increased frequency in patients with mood disorder. Table 4 shows the results of a combined analysis of data for rs2230912 from Barden et al. 15 and Lucae et al. 16 combined with the UCL bipolar data for 3586 individuals. This analysis showed significant allelic association (P = 0.0025) and genotypic association (P = 0.0005). The allelic and genotypic associations are explained by an increase of heterozygotes rather than homozygotes, which suggests a dominant mode of transmission (odds ratio 1.302, CI 1.129-1.503).
Conclusions
The results presented in this study replicate the previous mood disorder studies at the P2RX7 locus. [14] [15] [16] In particular we note that the same alleles were associated with mood disorders in all three studies. It is also relevant to point out that all three studies were carried out in European populations with the prior expectation that any associations found should be similar in the three samples. The two locus haplotype GENECOUNTING analysis revealed significant association with BPD using data from SNPs rs504677 (P2RX7-I07E) and rs2230912 (P2RX7-E13A) (global empirical P = 0.0079; Table 3 ). The direction of change for the associated haplotypes at these two loci is the same in the Canadian and UCL study. In the HAPLO-VIEW analysis of the UCL data haplotypes TG and TA are increased in the cases compared to control, and in the Canadian sample these two haplotypes are increased in cases compared to controls as well but did not reach significance. The allelic association findings with rs2230912 (P2RX7-E13A) are interesting because the G allele of this SNP alters a highly conserved glutamine residue in an SH-3 domain to 36 and may have effects on P2RX7-mediated signalling. Replication of the association between allele G at rs2230912 with affective disorder in further samples may require larger sample sizes than employed so far if the disease allele G has an odds ratio of p1.3.
P2RX7 is a member of the ATP receptor family. Depending on the level of stimulation, it acts as a cation-selective channel or a non-selective large conductance pore.
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P2RX7 agonism causes an increase in intracellular calcium that in some circumstances can lead to cell death. 38 Sites of brain expression include the hippocampus and pituitary gland. Studies of P2RX7 knockout mice have demonstrated that the receptor mediates ATP-induced ã-aminobutyric acid and glutamate transmission in the hippocampus. 39 P2RX7 may have a role to play in antidepressant action and susceptibility to mood disorders via its influence on hippocampal neurotransmission, 40 neuroprotection 41 or neuroinflammatory responses. 42 
